The effects of pemafibrate and Omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study) (vol 10, 1094100, 2023)
FRONTIERS IN CARDIOVASCULAR MEDICINE（2023）
关键词
apolipoprotein B-48,atherosclerotic cardiovascular disease,residual risk,hypertriglyceridemia,pemafibrate,polyunsaturated fatty acids
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要